Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes

  • R. A. De Fronzo
  • , C. F. Burant
  • , P. Fleck
  • , C. Wilson
  • , Q. Mekki
  • , R. E. Pratley

Research output: Contribution to journal › Article › peer-review

93 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology